HUP1600415A2 - Pimavanserin salts for the manufacture of pharmaceutical formulations - Google Patents

Pimavanserin salts for the manufacture of pharmaceutical formulations

Info

Publication number
HUP1600415A2
HUP1600415A2 HU1600415A HUP1600415A HUP1600415A2 HU P1600415 A2 HUP1600415 A2 HU P1600415A2 HU 1600415 A HU1600415 A HU 1600415A HU P1600415 A HUP1600415 A HU P1600415A HU P1600415 A2 HUP1600415 A2 HU P1600415A2
Authority
HU
Hungary
Prior art keywords
manufacture
pharmaceutical formulations
pimavanserin
salts
pimavanserin salts
Prior art date
Application number
HU1600415A
Other languages
Hungarian (hu)
Inventor
Dr Samu Erika Molnarne
Detrich Adam Dezsoe Dr
Dr Lauritz Maria Tothne
Volk Balazs Dr
Nagy Tamas Dr
Zoltan Varga
Laszlo Szlavik
Fadgyas Katalin Kataine
Adrienn Keszthelyi
Norbert Racz
Original Assignee
Egyt Gyogyszervegyeszeti Gyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egyt Gyogyszervegyeszeti Gyar filed Critical Egyt Gyogyszervegyeszeti Gyar
Priority to HU1600415A priority Critical patent/HU231097B1/en
Priority to PCT/HU2017/050027 priority patent/WO2018007842A1/en
Publication of HUP1600415A2 publication Critical patent/HUP1600415A2/en
Publication of HU231097B1 publication Critical patent/HU231097B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HU1600415A 2016-07-08 2016-07-08 Pimavanserin salts for the manufacture of pharmaceutical formulations HU231097B1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
HU1600415A HU231097B1 (en) 2016-07-08 2016-07-08 Pimavanserin salts for the manufacture of pharmaceutical formulations
PCT/HU2017/050027 WO2018007842A1 (en) 2016-07-08 2017-07-07 Pimavanserin salts useful for the production of a pharmaceutical preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU1600415A HU231097B1 (en) 2016-07-08 2016-07-08 Pimavanserin salts for the manufacture of pharmaceutical formulations

Publications (2)

Publication Number Publication Date
HUP1600415A2 true HUP1600415A2 (en) 2018-01-29
HU231097B1 HU231097B1 (en) 2020-08-28

Family

ID=89992212

Family Applications (1)

Application Number Title Priority Date Filing Date
HU1600415A HU231097B1 (en) 2016-07-08 2016-07-08 Pimavanserin salts for the manufacture of pharmaceutical formulations

Country Status (2)

Country Link
HU (1) HU231097B1 (en)
WO (1) WO2018007842A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115124456B (en) * 2021-03-26 2024-05-10 上海云晟研新生物科技有限公司 Pharmaceutical salt of pimavanserin, preparation method, pharmaceutical composition containing pharmaceutical salt and application of pharmaceutical composition

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006037043A1 (en) * 2004-09-27 2006-04-06 Acadia Pharmaceuticals Inc. Synthesis of n-(4-fluorobenzyl)-n-(1-methylpiperidin-4-yl)-n'-(4-(2-methylpropyloxy)phenylmethyl)carbamide and its tartrate salt and crystalline forms
US7790899B2 (en) * 2004-09-27 2010-09-07 Acadia Pharmaceuticals, Inc. Synthesis of N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N′-(4-(2-methylpropyloxy)phenylmethyl)carbamide and its tartrate salt and crystalline forms
CZ2015688A3 (en) * 2015-10-02 2017-04-12 Zentiva, K.S. A method of producing 1-(4-fluorobenzyl)-3-(4-isobutoxybenzyl)-1-(1-methylpiperidin-4-yl) of urea and its deuterated analogs

Also Published As

Publication number Publication date
WO2018007842A1 (en) 2018-01-11
HU231097B1 (en) 2020-08-28

Similar Documents

Publication Publication Date Title
HK1248570A1 (en) D2o stabilized pharmaceutical formulations
GB201612092D0 (en) Pharmaceutical compounds
GB201617630D0 (en) Pharmaceutical compounds
GB201617758D0 (en) Pharmaceutical compounds
PT4070787T (en) Pharmaceutical formulations
ZA201903101B (en) Pharmaceutical formulations
HK1254343A1 (en) Pharmaceutical formulations
GB201617627D0 (en) Pharmaceutical compounds
GB201612938D0 (en) Pharmaceutical compounds
GB201612095D0 (en) Pharmaceutical compounds
GB201617454D0 (en) Pharmaceutical compounds
PT3426294T (en) Pharmaceutical formulation
IL262745A (en) Improved drug formulations
ZA201707094B (en) Pharmaceutical formulations
IL266537A (en) Pharmaceutical formulation
ZA201807851B (en) Pharmaceutical formulation
GB201617871D0 (en) Pharmaceutical compounds
IL267279A (en) Pharmaceutical formulations of suvorexant
HUP1600415A2 (en) Pimavanserin salts for the manufacture of pharmaceutical formulations
HUP1600436A2 (en) Salts for the preparation of a pharmaceutical composition
GB201610440D0 (en) Pharmaceutical formulations
HK1226067B (en) Pharmaceutical compounds
GB201614037D0 (en) Pharmaceutical compounds
GB201604545D0 (en) Novel pharmaceutical formulation
GB201602861D0 (en) Pharmaceutical compounds